Evidence map›Paper›PMID 40699541›Full record

ArticleJournal of endocrinological investigation2025

Italian guidelines for the management of adult individuals with primary hypothyroidism outside pregnancy.

Rinaldo Guglielmi, Caterina Mian, Roberto Novizio, Agostino Paoletta, Agnese Persichetti, Irene Samperi, Alessandro Scoppola, Marcello Bagnasco, Ernesto De Menis, Maria Luisa De Rimini and 32 more

Abstract read
In one paragraph

Article in Journal of endocrinological investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Rinaldo Guglielmi *Lifenet Health Group, Endocrinology, Regina Apostolorum Hospital, Albano Laziale, RM, Italy.
Caterina Mian *Endocrinology, Department of Medicine DIMED, University of Padua, Padua, Italy.ORCID http://orcid.org/0000-0003-2615-8001
Roberto NovizioCatholic University of the Sacred Heart, Rome, Italy. robertonovizio@gmail.com.ORCID http://orcid.org/0000-0001-5641-6847
Agostino PaolettaEndocrinology, ULSS6 Euganea, Padua, Italy.
Agnese PersichettiMinistry of Interior - Department of Firefighters, Public Rescue and Civil Defense, Rome, Italy.ORCID http://orcid.org/0000-0003-2856-3764
Irene SamperiEndocrinology, ASL Novara, Novara, Italy.
Alessandro ScoppolaUOSD Endocrinologia, ASL Roma 1, Rome, Italy.ORCID http://orcid.org/0000-0002-6490-0978
Marcello BagnascoAIT President, Endocrinology Unit, Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, Genoa, Italy.
Ernesto De MenisInternal Medicine 2, Treviso Hospital, Treviso, Italy.ORCID http://orcid.org/0009-0009-6043-3725
Maria Luisa De RiminiAIMN President, Nuclear Medicine Unit, AORN Ospedali Dei Colli, Naples, Italy.
Marco RaffaelliCatholic University of the Sacred Heart, Rome, Italy.ORCID http://orcid.org/0000-0002-1259-2491
Maria Gabriella RugiuSOC di Otorinolaringoiatria, Ospedale di San Daniele e Tolmezzo, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.ORCID http://orcid.org/0000-0002-0565-2433
Claudio AndreoliAzienda ULSS 9 Scaligera, Verona, Italy.
Marco BoniardiEndocrine Surgery Unit, General Oncologic and Mini-invasive Surgery Department, ASST Grande Ospedale Metropolitano di Niguarda, Milan, Italy.
Giulia FiorentiniIRCCS San Raffaele, Rome, Italy.
Pietro LocantoreCatholic University of the Sacred Heart, Rome, Italy.ORCID http://orcid.org/0000-0002-4772-1417
Enrico PapiniLifenet Health Group, Endocrinology, Regina Apostolorum Hospital, Albano Laziale, RM, Italy.ORCID http://orcid.org/0000-0003-4790-2733
Federica PresciuttiniUOC Medicina - ASL, Rome, Italy.
Silvia RizzatiUOC Medicina Interna, Ospedale S. Maria della Misericordia, Rovigo, Italy.
Marsida TelitiUnit of Endocrinology and Metabolism, Department of Internal Medicine and Therapeutics, ICS Maugeri Pavia, University of Pavia, Pavia, Italy.ORCID http://orcid.org/0009-0007-4606-8923
Doris TinaUOC Malattie Endocrine e Diabetologia, PO Atri (TE), Milan, Italy.
Vincenzo TriggianiInterdisciplinary Department of Medicine, Endocrinology, Geriatrics and Rare Diseases, University of Bari "Aldo Moro", Bari, Italy.ORCID http://orcid.org/0000-0001-6308-0528
Annibale VersariNuclear Medicine, Azienda Unità Sanitaria Locale-IRCCS di, Reggio Emilia, Reggio Emilia, Italy.
Camilla ViriliEndocrinology Unit, Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.ORCID http://orcid.org/0000-0002-4973-1950
Marina VitilloClinical Pathology Unit, Laboratories Department, ASL Roma 1, Rome, Italy.
Michele BasileHigh School of Economy and Management of Health Systems, Catholic University of Sacred Heart, Rome, Italy.ORCID http://orcid.org/0000-0002-1098-2648
Fabio CrucianiDepartment of Epidemiology, Lazio Regional Health Service, ASL Roma 1, Rome, Italy.ORCID http://orcid.org/0000-0001-5533-8357
Zuzana MitrovaDepartment of Epidemiology, Lazio Regional Health Service, ASL Roma 1, Rome, Italy.ORCID http://orcid.org/0000-0002-7644-7939
Rosella SaulleDepartment of Epidemiology, Lazio Regional Health Service, ASL Roma 1, Rome, Italy.ORCID http://orcid.org/0000-0003-4358-0415
Ilaria ValentiniHigh School of Economy and Management of Health Systems, Catholic University of Sacred Heart, Rome, Italy.ORCID http://orcid.org/0000-0001-5940-7495
Mirco BartolomeiOnco-Hematology Department, Nuclear Medicine Unit, University Hospital of Ferrara, Ferrara, Italy.
Giulia BertinoDepartment of Otorhinolaryngology, Head and Neck Surgery, University of Pavia, Foundation IRCCS Policlinico San Matteo, Pavia, Italy.ORCID http://orcid.org/0000-0003-2840-5184
Pietro Giorgio CalòDepartment of Surgical Sciences, SIUEC Past President, University of Cagliari, Cagliari, Italy.ORCID http://orcid.org/0000-0001-9637-1145
Federica D'AurizioInstitute of Clinical Pathology, Department of Laboratory Medicine, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.ORCID http://orcid.org/0000-0003-2311-859X
Caterina Di CosmoEndocrinology, Ospedale Unico della Versilia, Azienda USL Toscana Nord Ovest, Pisa, Italy.
Andrea FrasoldatiEndocrinology, Arcispedale S. Maria Nuova IRCCS, ASL Reggio Emilia, Reggio Emilia, Italy.ORCID http://orcid.org/0000-0001-9002-9293
Massimo MarchettiDepartment of Internal Medicine, Hospital Alto Vicentino (AULSS-7 Veneto), Santorso, VI, Italy.
Rosa Elisa MiceliPrivate Practice, Rome, Italy.
Salvatore MontiFacoltà di Medicina e Psicologia, UOS Endocrinologia - UOC Medicina Specialistica Endocrino -Metabolica, AOU Sant'Andrea, Sapienza Università di Roma, Rome, Italy.
Alfredo PontecorviCatholic University of the Sacred Heart, Rome, Italy.ORCID http://orcid.org/0000-0003-0570-6865
Mario RotondiUnit of Endocrinology and Metabolism, Department of Internal Medicine and Therapeutics, ICS Maugeri Pavia, University of Pavia, Pavia, Italy.ORCID http://orcid.org/0000-0001-6464-2334
Roberto AttanasioAME Scientific Committee, Milan, Italy.ORCID http://orcid.org/0000-0002-1417-287X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe present guideline (GL) is aimed to improve and standardize the treatment of primary hypothyroidism in non-pregnant adults and to offer all the patients the best possible care across the Italian country. TARGET POPULATION: Non-pregnant adults with hypothyroidism. EXCLUDED POPULATION: This GL does not cover the treatment of hypothyroidism in children and adolescents under 18 years of age, in women who are pregnant or breastfeeding, nor in subjects with central hypothyroidism. Also patients who require suppressive therapy with levothyroxine after thyroidectomy for thyroid cancer and those with transient iatrogenic hypothyroidism were not considered in this GL.

methodsThe direct costs and the utilization of resources over time were evaluated for the implementation of the appropriate management within the National Health Service. Recommendations were based on the analysis, according to the GRADE methodology, of the evidence from literature. Patients preferences were collected and verified by means of specific bibliographic research and the active participation of two patients' representatives in the GL development group.

resultsThe present GL provides 4 formal graded recommendations and 16 ungraded indications for good clinical practice. An elevated agreement was consistently obtained among the panel members.

conclusionsThe present GL provides operative recommendations-based on the best available evidence and cost-effectiveness analysis-for the treatment of adult patients with primary hypothyroidism. The expected benefits from the dissemination, application and implementation of this GL are the improvement of the quality of care, its homogenization across the national territory and the rationalization of health expenditure in the respect of patient preferences.

Indexed as

HypothyroidismPractice Guidelines as TopicAdultDisease ManagementFemaleHumansItalyPregnancyThyroxineThyroxineDesiccated thyroid extractsHypothyroidismQuality of lifeThyroidThyroxineTriiodothyronine

Identifiers

PMID40699541
PMCPMC12518491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.